We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
CONMED
CNMD
$1.26B
| $491K | ﹤0.01% |
5,902
-896
| -13% | -$65.1K |
|
1377
Knowles
KN
$3.13B
| $491K | ﹤0.01% |
27,866
+277
| +1% | +$4.29K |
|
1378
Assured Guaranty
AGO
$3.74B
| $490K | ﹤0.01% |
11,019
-18,531
| -63% | -$772K |
|
1379
NiSource
NI
$22.3B
| $489K | ﹤0.01% |
17,070
-7,362
| -30% | -$198K |
|
1380
Teradata
TDC
$2.64B
| $487K | ﹤0.01% |
11,152
-6,152
| -36% | -$276K |
|
|
CKH
1381
DELISTED
Seacor Holdings Inc.
CKH
| $485K | ﹤0.01% |
11,482
+906
| +9% | +$38.6K |
|
1382
Viasat
VSAT
$10.2B
| $483K | ﹤0.01% |
6,237
-170
| -3% | -$11.8K |
|
|
CSGS
1383
DELISTED
CSG Systems International
CSGS
| $480K | ﹤0.01% |
11,338
-1,266
| -10% | -$48.9K |
|
1384
New York Times
NYT
$11.8B
| $479K | ﹤0.01% |
14,580
-2,094
| -13% | -$62K |
|
1385
Fortune Brands Innovations
FBIN
$5.99B
| $478K | ﹤0.01% |
11,756
-1,246
| -10% | -$47.8K |
|
1386
Safety Insurance
SAFT
$1.06B
| $478K | ﹤0.01% |
5,489
+419
| +8% | +$35.9K |
|
1387
Healthcare Services Group
HCSG
$1.62B
| $477K | ﹤0.01% |
14,469
+3,537
| +32% | +$135K |
|
|
WRI
1388
DELISTED
Weingarten Realty Investors
WRI
| $476K | ﹤0.01% |
+16,223
| New | +$454K |
|
1389
Papa John's
PZZA
$1.05B
| $467K | ﹤0.01% |
8,827
+104
| +1% | +$4.59K |
|
1390
Helen of Troy
HELE
$657M
| $466K | ﹤0.01% |
4,020
+1,256
| +45% | +$145K |
|
1391
PRA Group
PRAA
$645M
| $464K | ﹤0.01% |
17,315
-386
| -2% | -$11.2K |
|
|
HOLI
1392
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $462K | ﹤0.01% |
22,049
+4,507
| +26% | +$92.7K |
|
1393
AZZ Inc
AZZ
$4.53B
| $461K | ﹤0.01% |
11,267
+564
| +5% | +$25K |
|
|
IVC
1394
DELISTED
Invacare Corporation
IVC
| $461K | ﹤0.01% |
55,134
-46,849
| -46% | -$337K |
|
1395
ONE Gas
OGS
$5.04B
| $460K | ﹤0.01% |
5,164
+505
| +11% | +$42.4K |
|
|
UNT
1396
DELISTED
UNIT Corporation
UNT
| $458K | ﹤0.01% |
32,137
+7,401
| +30% | +$118K |
|
|
NCI
1397
DELISTED
Navigant Consulting, Inc.
NCI
| $458K | ﹤0.01% |
23,517
+3,366
| +17% | +$78.7K |
|
1398
Piper Sandler
PIPR
$5.15B
| $456K | ﹤0.01% |
25,032
+204
| +0.8% | +$3.62K |
|
1399
CoreCivic
CXW
$3.18B
| $454K | ﹤0.01% |
23,325
+3,051
| +15% | +$60.2K |
|
1400
Gen Digital
GEN
$15.4B
| $453K | ﹤0.01% |
19,723
+158
| +0.8% | +$3.44K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.